ArticleFrontiers in neurology2026

Cytokine-induced killer cells combined with temozolomide suppress glioblastoma progression in an orthotopic model and demonstrate clinical feasibility in recurrent glioblastoma.

Young Kyu Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.